ISIS: interaction sites identified from sequence.

Bioinformatics

CUBIC & North-East Structural Genomics Consortium, Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.

Published: January 2007

Motivation: Large-scale experiments reveal pairs of interacting proteins but leave the residues involved in the interactions unknown. These interface residues are essential for understanding the mechanism of interaction and are often desired drug targets. Reliable identification of residues that reside in protein-protein interface typically requires analysis of protein structure. Therefore, for the vast majority of proteins, for which there is no high-resolution structure, there is no effective way of identifying interface residues.

Results: Here we present a machine learning-based method that identifies interacting residues from sequence alone. Although the method is developed using transient protein-protein interfaces from complexes of experimentally known 3D structures, it never explicitly uses 3D information. Instead, we combine predicted structural features with evolutionary information. The strongest predictions of the method reached over 90% accuracy in a cross-validation experiment. Our results suggest that despite the significant diversity in the nature of protein-protein interactions, they all share common basic principles and that these principles are identifiable from sequence alone.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btl303DOI Listing

Publication Analysis

Top Keywords

isis interaction
4
interaction sites
4
sites identified
4
identified sequence
4
sequence motivation
4
motivation large-scale
4
large-scale experiments
4
experiments reveal
4
reveal pairs
4
pairs interacting
4

Similar Publications

For decades, extensive surfactant libraries have been developed to meet the requirements of downstream applications. However, achieving functional diversity has traditionally demanded a vast array of chemical motifs and synthetic pathways. Herein, a new approach for surfactant design based on structural isomerism is utilised to access a wide spectrum of functionalities.

View Article and Find Full Text PDF

High-rate quantum error correcting (QEC) codes with moderate overheads in qubit number and control complexity are highly desirable for achieving fault-tolerant quantum computing. Recently, quantum error correction has experienced significant progress both in code development and experimental realizations, with neutral atom qubit architecture rapidly establishing itself as a leading platform in the field. Scalable quantum computing will require processing with QEC codes that have low qubit overhead and large error suppression, and while such codes do exist, they involve a degree of non-locality that has yet to be integrated into experimental platforms.

View Article and Find Full Text PDF

Label-free 3D cell imaging using hydrogels functionalized with switchable iridium complexes.

Chemistry

January 2025

Istituto di Ricerche Farmacologiche Mario Negri, Laboratory of Biochemistry and Protein Chemistry, Via Mario Negri, 2, 20156, Milano, ITALY.

The use of fluorescent labels is the most common tool to visualize cells. However, the internalization of dye molecules often modifies the cell behavior. In this paper we demonstrate that it is possible to transiently label cells using a 3D scaffold, a hydrogel, covalently functionalized with luminescent cyclometalated iridium(III) complexes.

View Article and Find Full Text PDF

The hypoxic microenvironment is crucial for tumour cell growth and invasiveness. Tumour tissue results from adaptation to reduced oxygen availability. Hypoxia first activates pro-angiogenic signals for alleviation.

View Article and Find Full Text PDF

Protecting monoclonal antibodies via competitive interfacial adsorption of nonionic surfactants.

J Colloid Interface Sci

April 2025

Biological Physics Laboratory, Department of Physics and Astronomy, University of Manchester, Oxford Road, Schuster Building, Manchester M13 9PL, UK. Electronic address:

Hypothesis: Bioengineered monoclonal antibodies (mAbs) have gained significant recognition as medical therapies. However, during processing, storage and use, mAbs are susceptible to interfacial adsorption and desorption, leading to structural deformation and aggregation, and undermining their bioactivity. To suppress antibody surface adsorption, nonionic surfactants are commonly used in formulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!